The DZHK has a clear mission: We want to develop new therapies and diagnostic procedures that have an impact on the lives of people suffering from cardiovascular diseases. To achieve this, we aim to transfer results from basic research into clinical practice fast and efficient. This is why the DZHK brings together outstanding basic and clinical researchers from seven partner sites in Germany. It fosters cooperation between scientists with the aim of developing synergies and thus accelerating the process of translation. The DZHK primarily invests its funds in the translation process based on a coordinated research strategy and specific funding instruments.
The DZHK was established in 2012 on the initiative of the Federal Ministry of Education and Research. In addition to the DZHK, there are five more German Centres for Health Research which are dedicated to research into widespread diseases.
Loss of healthy life years
Why is that important? Cardiovascular diseases continue to increase and are still the number one cause of death in Germany. They burden the health system far more than cancers. They are often chronic and deprive people of healthy years of life compared to other diseases. So more and more people live for a very long time with heart failure, heart valve diseases or cardiac arrhythmia. The healthcare system and research must respond to this. The most important reason is that people are getting older and older.
Joining forces to fight heart disease
Research at the DZHK is intended to help reduce the number of people dying from cardiovascular diseases and improve the quality of life of those affected. Our research focuses on heart diseases that are very common in the general population. These include in particular heart failure, heart attack, atrial fibrillation and sudden cardiac death.